ClinicalTrialsFinder

Relapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Clinical Trials in Nagoya, Aichi-ken

1 recruitingNagoya, Aichi-ken, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL

Relapsed or Refractory T Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Ono Pharmaceutical Co., Ltd.108 enrolled14 locationsNCT06547528